Open Journal of Endocrine and Metabolic Diseases
Vol.6 No.1(2016), Paper ID 62894, 15
pages
DOI:10.4236/ojemd.2016.61007
Extra Glycemic Impacts of GLP-1 Receptor Agonists: Benefits of a Class Effect?
Lis Marina de Mesquita Araújo, Sumaya Feguri, Thereza Lopes de Oliveira, Fernanda Batista Pedrosa, Rodrigo Garcez Guimarães, Larissa Bianca Paiva Cunha de Sá, Denise Rosso Tenório Wanderley Rocha, Alberto Krayyem Arbex
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Division of Endocrinology, IPEMED Medical School, Belo Horizonte, Brazil
Harvard T. H. Chan School of Public Health, Boston, USA
Copyright © 2016 Lis Marina de Mesquita Araújo, Sumaya Feguri, Thereza Lopes de Oliveira, Fernanda Batista Pedrosa, Rodrigo Garcez Guimarães, Larissa Bianca Paiva Cunha de Sá, Denise Rosso Tenório Wanderley Rocha, Alberto Krayyem Arbex et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
de Mesquita Araújo, L. , Feguri, S. , de Oliveira, T. , Pedrosa, F. , Guimarães, R. , de Sá, L. , Rocha, D. and Arbex, A. (2016) Extra Glycemic Impacts of GLP-1 Receptor Agonists: Benefits of a Class Effect?.
Open Journal of Endocrine and Metabolic Diseases,
6, 43-57. doi:
10.4236/ojemd.2016.61007.